People
Academic Staff

Prof. HUI Shu Cheong, David, BBS, JP
MBBS (UNSW); MD(UNSW); FRACP; FRCP (Lond, Glasg, Edin); FHKCP; FHKAM

Director, SH Ho Research Center in Infectious Diseases and Stanley Ho Centre for Emerging Infections Diseases, School of Public Health & Primary Care, Faculty of Medicine, CUHK
Stanley Ho Professor of Respiratory Medicine, Dept of Medicine & Therapeutics, CUHK.
Director, SH Ho Sleep Apnoea Management Center, Dept of Medicine & Therapeutics, CUHK.

Tel: (852) 3505 3128
Email: dschui@cuhk.edu.hk
ORCID: 0000-0003-4382-2445

Biography

Dr Hui graduated from the University of New South Wales in 1985. He then trained in Respiratory Medicine and Sleep Medicine in Sydney, Australia.

Dr Hui was heavily involved in the clinical management of patients with SARS at the Prince of Wales Hospital during the major outbreak in 2003. He served as a WHO advisor to review the clinical management of influenza A(H5N1) during the early human outbreak in Vietnam in Feb 2004 and has since been a regular advisor to the WHO on the clinical management of severe acute respiratory infections. He joined urgent WHO missions for investigation of outbreaks of MERS in Riyadh and South Korea in 2013 and 2015 respectively. He has contributed to the WHO treatment guidelines including the clinical management of influenza A (H5N1) virus in 2007, clinical management of influenza A (H1N1) pandemic in 2009, and the Middle East Respiratory Syndrome (MERS) and the WHO training workshop in the clinical management of influenza A(H7N9) and COVID-19. He served as an Expert Advisory Panel member to the Steering Committee cum Command Center during the COVID-19 pandemic chaired by the Chief Executive, HKSAR government from 29 Jan 2020 to 30 May 2023. In addition, he has served as the Chairman of the Scientific Committee on Emerging & Zoonotic Diseases and a member of the Scientific Committee on Vaccine Preventable Diseases under the Center for Health Protection since 2019.

Dr Hui has published over 500 peer-reviewed journal articles and 24 book chapters since joining the CUHK in 1998. Clarivate top 1% highly researcher from 2021 to 2025. H index 99 (Scopus) and 91 (Web of Science) with over 500 peer-reviewed journal articles by March 2026.

Research Interests

Clinical management of emerging severe acute respiratory infections, the safety of respiratory therapy in the post SARS era, the efficacy of the medical ward airflow in preventing nosocomial infections, sleep disordered breathing, and common airway diseases.

Selected Publications